# A Pharmacodynamic Study of Dapoxetine Concomitantly Administered in Participants Taking Terazosin

> **NCT01366664** · PHASE1 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 24 (actual)

## Conditions studied

- Ejaculation

## Interventions

- **DRUG:** Treatment sequence 2
- **DRUG:** Treatment sequence 1

## Key facts

- **NCT ID:** NCT01366664
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2014-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01366664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01366664, "A Pharmacodynamic Study of Dapoxetine Concomitantly Administered in Participants Taking Terazosin". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01366664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*